These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Potent and specific inhibition of IL-8-, IL-1 alpha- and IL-1 beta-induced in vitro human lymphocyte migration by calcium channel antagonists. Bacon KB; Westwick J; Camp RD Biochem Biophys Res Commun; 1989 Nov; 165(1):349-54. PubMed ID: 2686646 [TBL] [Abstract][Full Text] [Related]
43. Mediation of chemoattractant-induced changes in [Ca2+]i and cell shape, polarity, and locomotion by InsP3, DAG, and protein kinase C in newt eosinophils. Gilbert SH; Perry K; Fay FS J Cell Biol; 1994 Oct; 127(2):489-503. PubMed ID: 7929591 [TBL] [Abstract][Full Text] [Related]
44. Measuring chemotaxis of polymorphonuclear leukocytes with the "sparse-pore" polycarbonate membrane in the Boyden chamber: chemotactic activity of rheumatoid synovial fluid. Bignold LP Arch Immunol Ther Exp (Warsz); 1992; 40(1):33-7. PubMed ID: 1485825 [No Abstract] [Full Text] [Related]
45. Evaluation of signal transduction pathways in chemoattractant-induced human monocyte chemotaxis. Fine JS; Byrnes HD; Zavodny PJ; Hipkin RW Inflammation; 2001 Apr; 25(2):61-7. PubMed ID: 11321360 [TBL] [Abstract][Full Text] [Related]
46. Effect of bacterial products on neutrophil chemotaxis. Kalmar JR; Van Dyke TE Methods Enzymol; 1994; 236():58-87. PubMed ID: 7968641 [No Abstract] [Full Text] [Related]
47. Mediation of macrophage reactions in immune tissue injury. Honda M; Yoshimura T; Miura K; Hayashi H Acta Pathol Jpn; 1985 Mar; 35(2):269-80. PubMed ID: 3861071 [TBL] [Abstract][Full Text] [Related]
49. Intravital demonstration of modulation of T lymphocyte migration by CINC/gro in rat Peyer's patches. Fujimori H; Miura S; Koseki S; Hokari R; Tsuzuki Y; Komoto S; Hara Y; Suzuki H; Serizawa H; Ishii H Digestion; 2001; 63 Suppl 1():97-102. PubMed ID: 11173918 [TBL] [Abstract][Full Text] [Related]
50. Characterization of a novel chemotactic factor for neutrophils in the bronchial secretions of patients with cystic fibrosis. Dudez TS; Chanson M; Schlegel-Haueter SE; Suter S J Infect Dis; 2002 Sep; 186(6):774-81. PubMed ID: 12198611 [TBL] [Abstract][Full Text] [Related]
51. H2O2: a chemoattractant? Enyedi B; Niethammer P Methods Enzymol; 2013; 528():237-55. PubMed ID: 23849869 [TBL] [Abstract][Full Text] [Related]
52. Lymphocyte locomotion "in vitro": the role of growth activators and chemoattractants. Wilkinson PC Biomed Pharmacother; 1987; 41(6):329-36. PubMed ID: 3328629 [TBL] [Abstract][Full Text] [Related]
53. Lymphocyte chemotaxis in inflammation. X. Heterogeneity of chemotactic responsiveness in human T subsets towards lymphocyte chemotactic factors from delayed hypersensitivity reaction site. Mibu Y; Shimokaway Y; Hayashi H Immunology; 1985 Jul; 55(3):473-9. PubMed ID: 3874818 [TBL] [Abstract][Full Text] [Related]
54. Inhibition of T cell recruitment and cutaneous delayed-type hypersensitivity-induced inflammation with antibodies to monocyte chemoattractant protein-1. Rand ML; Warren JS; Mansour MK; Newman W; Ringler DJ Am J Pathol; 1996 Mar; 148(3):855-64. PubMed ID: 8774140 [TBL] [Abstract][Full Text] [Related]
55. Pituitary adenylate cyclase-activating polypeptide (PACAP38) modulates lymphocyte and macrophage functions: stimulation of adherence and opposite effect on mobility. Garrido E; Delgado M; Martínez C; Gomariz RP; De la Fuente M Neuropeptides; 1996 Dec; 30(6):583-95. PubMed ID: 9004257 [TBL] [Abstract][Full Text] [Related]